Sustained Therapeutic Efficacy of Humanized Anti-CD19 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Acute Lymphoblastic LeukemiaCLINICAL CANCER RESEARCHIF10.22020-04-0156OAAI